Nivolumab vs Sertraline
Nivolumab vs Sertraline: Overview
This comparison examines the pharmacological differences between Nivolumab and Sertraline.
Mechanism of Action
Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.
Sertraline: Selective serotonin reuptake inhibitor (SSRI).
Pharmacokinetics
Half-life: Nivolumab — 27 days; Sertraline — 26 hours.
Chemical Properties
Molecular Formula: Sertraline — C17H17Cl2N.
Molecular Weight: Sertraline — 306.2290 g/mol.
Type: Nivolumab — Antibody; Sertraline — Small molecule.